Physician profile
Walid Hadid
NPI 1871549816
$1,693.27
in general payments reported to CMS, 2019-2025
16 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.43 · 2020: $25.05 · 2023: $778 · 2024: $367 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,348 · Travel and Lodging: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,347.72 |
| Travel and Lodging | $304.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $676.41 | 2023-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Intuitive Surgical, INC. | $441.50 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $148.21 | 2023-2024 | Glassia |
| Noah Medical Corporation | $133.31 | 2023 | |
| Glaxosmithkline, LLC. | $51.41 | 2025 | Nucala, Trelegy Ellipta |
| Electromed, INC. | $31.99 | 2025 | Smartvest |
| Abbvie INC. | $30.12 | 2025 | |
| Allergan, INC. | $30.02 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $26.17 | 2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $23.04 | 2024 | Acthar |
| Insmed, INC. | $20.02 | 2024 | Arikayce |
| Cook Medical LLC | $19.10 | 2025 | Blue Rhino |
| Olympus America INC. | $17.71 | 2024 | |
| Philips North America LLC | $16.53 | 2024 | (Ak6) Vest Therapy |
| Astrazeneca Pharmaceuticals LP | $16.27 | 2024 | Tezspire |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walid Hadid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.